Patricia Kohlhof-Meinecke
Has participated in:
-
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types
-
Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors
-
Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors